- Barclays (LSE:BARC) is under investigation by the Bank of England over how it classifies derivatives linked to illiquid private credit loans.
- The regulatory review focuses on whether the bank treated these contracts as lower risk than underlying private credit exposures in its internal models.
- Supervisors are examining potential implications for Barclays' calculated capital requirements and reported risk-weighted assets under existing UK rules.
- This probe into Barclays' private credit linked derivatives is an important counterweight to weigh alongside the rest of our research. Our analysis turns up 5 other big wins for Barclays as well.
For readers watching Barclays closely, it can help to compare it with other banking stocks that screen as more resilient on risk metrics 4 resilient stocks with low risk scores.
Barclays is a £55.7b banking group that provides lending, trading and advisory services across the UK and multiple international markets. Its treatment of private credit linked derivatives speaks directly to how it manages complex risks inside a globally active balance sheet.
See how Barclays's balance sheet measures up.
What exactly is the Bank of England looking at with Barclays?
Supervisors are reviewing how Barclays classifies derivatives tied to illiquid private credit loans in its internal risk models. The key point is whether these contracts were treated as lower risk than the underlying loans, which would affect reported risk weighted assets and the capital the group needs to hold against them.
Does this Barclays news change the existing Narrative around the stock?
The current Narrative leans on strong returns and a shift toward more capital efficient businesses, supported by stable structural hedge income and digital projects. A probe into complex credit exposures pulls directly on the listed risks around fraud, securitized products and legal issues. It does not overturn the thesis but it does put more weight on those downside scenarios.
See how these catalysts shape Barclays' path to a £5.75 fair value.
What should you watch next to judge the financial impact on Barclays?
The most useful markers are whether the inquiry leads to a formal finding, a restatement of risk weighted assets or a change in Barclays' disclosed capital ratios over the next few reporting periods. Any requirement to hold extra capital, pay a fine or adjust internal models would show up in those numbers and in future regulatory updates.
Add Barclays to your Watchlist and get alerts as these catalysts play out.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com